VBL Therapeutics reminds shareholders vote for proposed merger with Notable Lab

VBL Therapeutics reminds its shareholders to vote in favor of the previously announced proposed merger with Notable Labs at the annual and special meeting for shareholders of record as of September 5, 2023. All VBL shareholders, regardless of number of ordinary shares, nominal value of NIS 0.01 held, are encouraged to vote “FOR” the Merger and related proposals described in the definitive proxy statement/prospectus/information statement previously filed by VBL with the U.S. Securities and Exchange Commission in connection with the Meeting. If the relevant proposals at the Meeting are approved, the parties anticipate that the Merger will close within a few days thereafter, subject to the satisfaction of all other closing conditions. VBL Ordinary Shares are currently listed on The Nasdaq Capital Market under the symbol “VBLT“. After completion of the Merger, VBL is expected to be renamed “Notable Labs, Ltd.” and trade on The Nasdaq Capital Market under the symbol “NTBL”.